Arsenic liver toxicity pathway (Homo sapiens)
From WikiPathways
Description
This is an adverse outcome pathway of arsenic toxicity on liver including key processes leading to arsenic induced liver cancer.
Quality Tags
Ontology Terms
Bibliography
- Angrish MM, Allard P, McCullough SD, Druwe IL, Helbling Chadwick L, Hines E, Chorley BN; ''Epigenetic Applications in Adverse Outcome Pathways and Environmental Risk Evaluation.''; Environ Health Perspect, 2018 PubMed Europe PMC Scholia
History
View all... |
External references
DataNodes
View all... |
Name | Type | Database reference | Comment |
---|---|---|---|
Arsenic | |||
Cell cycle | Pathway | WP179 (WikiPathways) | |
DNA damage response | Pathway | WP707 (WikiPathways) | |
KE1194: Increase, DNA damage | 1194 (AOP-Wiki KE) | ||
KE1395: Liver Cancer | 1395 (AOP-Wiki KE) | ||
KE1487:Binding, Thiol/seleno-proteins involved in protection against oxidative stress | 1487 (AOP-Wiki KE) | ||
KE1894: Chronic low grade systemic inflammation | 1894 (AOP-Wiki KE) | ||
KE1940: Up-regulation of Reactive Oxygen Species | 1940 (AOP-Wiki KE) | ||
KE1969: Increase, Oxidative Stress | 1969 (AOP-Wiki KE) | ||
KE716: Increase, cell proliferation (hepatocytes) | 716 (AOP-Wiki KE) | ||
NRF2 pathway | Pathway | WP2884 (WikiPathways) | |
Oxidative damage response | Pathway | WP3941 (WikiPathways) | |
Phase II - Conjugation of compounds | Pathway | WP4111 (WikiPathways) | |
TNF-alpha signaling pathway | Pathway | WP231 (WikiPathways) |
Annotated Interactions
No annotated interactions